- Home
- BWB vs OABI Comparison
BWB vs OABI Comparison
Compare BWB & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWB
- OABI
- Stock Information
- Founded
- BWB 2005
- OABI 2012
- Country
- BWB United States
- OABI United States
- Employees
- BWB N/A
- OABI N/A
- Industry
- BWB Major Banks
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- BWB Finance
- OABI Health Care
- Exchange
- BWB Nasdaq
- OABI Nasdaq
- Market Cap
- BWB 365.0M
- OABI 421.1M
- IPO Year
- BWB 2018
- OABI N/A
- Fundamental
- Price
- BWB $13.76
- OABI $3.26
- Analyst Decision
- BWB Strong Buy
- OABI Strong Buy
- Analyst Count
- BWB 2
- OABI 4
- Target Price
- BWB $17.50
- OABI $9.00
- AVG Volume (30 Days)
- BWB 44.9K
- OABI 531.0K
- Earning Date
- BWB 04-23-2025
- OABI 03-18-2025
- Dividend Yield
- BWB N/A
- OABI N/A
- EPS Growth
- BWB N/A
- OABI N/A
- EPS
- BWB 1.03
- OABI N/A
- Revenue
- BWB $106,036,000.00
- OABI $20,409,000.00
- Revenue This Year
- BWB $26.46
- OABI N/A
- Revenue Next Year
- BWB $12.13
- OABI $78.61
- P/E Ratio
- BWB $13.48
- OABI N/A
- Revenue Growth
- BWB N/A
- OABI N/A
- 52 Week Low
- BWB $10.52
- OABI $3.05
- 52 Week High
- BWB $16.00
- OABI $5.72
- Technical
- Relative Strength Index (RSI)
- BWB 45.62
- OABI 41.10
- Support Level
- BWB $13.52
- OABI $3.05
- Resistance Level
- BWB $14.21
- OABI $3.46
- Average True Range (ATR)
- BWB 0.32
- OABI 0.15
- MACD
- BWB -0.08
- OABI -0.04
- Stochastic Oscillator
- BWB 31.44
- OABI 23.16
About BWB Bridgewater Bancshares Inc.
Bridgewater Bancshares Inc offers retail and commercial loan and deposit services to customers within the Minneapolis-St. Paul-Bloomington, MN-WI Metropolitan Statistical Area. The company engages in providing a wide range of deposit and lending products. Its products and services include commercial deposits, loans, online business services, credit card, mobile banking, and remote deposit services.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.